Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

Two monoclonal antibodies appeared safe and tolerable when administered alone or in combination to newborns exposed to HIV, according to a proof-of-concept study presented at the International AIDS ...

Thailand is examining the feasibility of adopting new global guidelines on long-acting HIV prevention, following the World Health Organisation's (WHO) launch of its latest recommendations for ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

Scientists, researchers, policy makers and HIV/AIDS advocates at a meeting in Kigali, Rwanda, from July 13-17 for the 13th ...

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...

The International AIDS Society has announced the 2022 International AIDS Conference will take place in-person in Montreal. The conference, which will also feature virtual events, is scheduled to take ...

As noted at AIDS 2022 by Dr. Chris Beyrer, the past president of the International AIDS Society and a professor public health at the Johns Hopkins University Bloomberg School of Public Health, ...